Denis Chem Lab Ltd

For the sixth consecutive session, Denis Chem Lab Ltd has closed lower, culminating in a fresh 52-week low of Rs 61.25 on 27 Mar 2026. This marks a 14.65% decline over the past six days, underscoring sustained selling pressure despite pockets of positive financial data.

Denis Chem Lab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date analysis.

For the fifth straight session, Denis Chem Lab Ltd closed lower, breaching its 52-week low at Rs 61.36 on 25 Mar 2026, marking a 10.65% decline over this period amid a broader market rally.

For the third consecutive session, Denis Chem Lab Ltd has closed lower, culminating in a fresh 52-week low of Rs 64.1 on 23 Mar 2026. This marks an 11.27% decline over the past three days, underscoring persistent selling pressure despite some pockets of strength in the broader market.

Denis Chem Lab Ltd’s shares declined to a fresh 52-week low of Rs.66.31 on 17 Mar 2026, marking a significant downturn amid a broader market environment where the Sensex showed modest gains. The stock has underperformed its sector and key benchmarks, reflecting ongoing pressures on its valuation and performance metrics.

Denis Chem Lab Ltd’s shares declined sharply to a fresh 52-week low of Rs.67.1 on 16 Mar 2026, marking a significant downturn amid broader market fluctuations and company-specific performance trends. The stock has now recorded a consecutive two-day fall, accumulating a loss of 6.65% over this period, underperforming its sector and broader indices.

Denis Chem Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Denis Chem Lab Ltd’s shares declined sharply to a new 52-week low of Rs.68.5 on 13 Mar 2026, marking a significant downturn amid broader market weakness and sector underperformance. The stock’s fall of 5.33% intraday outpaced the Pharmaceuticals & Biotechnology sector’s decline, reflecting ongoing pressures on the micro-cap company’s valuation and performance metrics.

Denis Chem Lab Ltd’s shares declined to a fresh 52-week low of Rs.70.05 today, marking a significant milestone in the stock’s downward trajectory over the past year. This new low reflects ongoing challenges in the company’s market performance and broader sector dynamics.

Denis Chem Lab Ltd’s shares declined to a fresh 52-week low of Rs.70.05 on 4 March 2026, marking a significant milestone in the stock’s downward trajectory over the past year. This new low reflects ongoing pressures on the company’s market performance amid broader sectoral and market dynamics.

Denis Chem Lab Ltd’s shares declined sharply to a fresh 52-week low of Rs.71.6 on 2 March 2026, marking a significant downturn amid persistent underperformance relative to its sector and broader market indices.

Denis Chem Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 February 2026. This revision reflects a combination of deteriorating technical indicators, a more attractive valuation profile, and mixed financial trends that collectively suggest caution for investors despite some positive quarterly results.

Denis Chem Lab Ltd has seen its investment rating upgraded from Sell to Hold as of 20 February 2026, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing challenges in financial trends and quality parameters. The company’s Mojo Score now stands at 51.0, signalling a cautious but more optimistic stance from analysts.

Denis Chem Lab Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, driven by a notable decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This revaluation comes despite a challenging year for the company’s stock price relative to the broader market, signalling a potential opportunity for investors seeking value in the Pharmaceuticals & Biotechnology sector.

Denis Chem Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 March 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Denis Chem Lab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 March 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.